(Q39794212)

14 September 2017

title

N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection (English)

1 reference

14 September 2017

0 references

11

Richard W Titball

1 reference

14 September 2017

4

Angus Best

1 reference

14 September 2017

Jim Hill

1

1 reference

14 September 2017

Sophie Leary

2

1 reference

14 September 2017

Sophie Smither

3

1 reference

14 September 2017

Jonas Pettersson

5

1 reference

14 September 2017

Ake Forsberg

6

1 reference

14 September 2017

Bry Lingard

7

1 reference

14 September 2017

Alexandria Lipka

8

1 reference

14 September 2017

Katherine A Brown

9

1 reference

14 September 2017

E Diane Williamson

10

1 reference

14 September 2017

language of work or name

English

0 references

publication date

26 September 2009

1 reference

14 September 2017

1 reference

14 September 2017

volume

27

1 reference

14 September 2017

issue

50

1 reference

14 September 2017

page(s)

7073-7079

1 reference

describes a project that uses

14 September 2017

1 reference

Factors promoting acute and chronic diseases caused by yersiniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Microevolution and history of the plague bacillus, Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

The type III secretion injectisome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Interactions of the type III secretion pathway proteins LcrV and LcrG from Yersinia pestis are mediated by coiled-coil domains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Individual chaperones required for Yop secretion by Yersinia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Administration of antibody to the lung protects mice against pneumonic plague.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Expression of a recombinant form of the V antigen of Yersinia pestis, using three different expression systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Probing molecular interactions in intact antibody: antigen complexes, an electrospray time-of-flight mass spectrometry approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Function and molecular architecture of the Yersinia injectisome tip complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Small protective fragments of the Yersinia pestis V antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

inferred from DOI database lookup

7 January 2021

based on heuristic

Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

inferred from DOI database lookup

7 January 2021

based on heuristic

Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.09.061

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.09.061

1 reference

14 September 2017

1 reference